An International Observational Registry Study to Further Describe Long-term Safety and Effectiveness of Palovarotene in Patients with Fibrodysplasia Ossificans Progressiva (FOP) (FOPal) First published 02/04/2024 Last updated 06/10/2025 EU PAS number:EUPAS1000000060 Study Ongoing